The creation of an antithrombotic surface by apyrase immobilization.

[1]  C. Alessandri,et al.  Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterization. , 1979, Transactions - American Society for Artificial Internal Organs.

[2]  B. van der Lei,et al.  Reduced thrombogenicity of artificial materials by coating with ADPase. , 1991, Biomaterials.

[3]  A. Kastrati,et al.  Time Course of Restenosis During the First Year After Emergency Coronary Stenting , 1993, Circulation.

[4]  A. Marcus,et al.  The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. , 1997, The Journal of clinical investigation.

[5]  ChristianGachet,et al.  ADP Receptors and Clinical Bleeding Disorders , 1999 .

[6]  B. Nilsson,et al.  A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. , 1999, Biomaterials.

[7]  K. Clemetson,et al.  The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. , 2000, Blood.

[8]  S. Diamond,et al.  Neutrophil Enhancement of Fibrin Deposition Under Flow Through Platelet-Dependent and -Independent Mechanisms , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[9]  B. Nilsson,et al.  Contact between a polymer and whole blood: sequence of events leading to thrombin generation. , 2001, The Journal of laboratory and clinical medicine.

[10]  Yuan Zhang,et al.  Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. , 2002, The Journal of clinical investigation.

[11]  G. Elgue,et al.  Measuring the degree of plasma contact activation induced by artificial materials. , 2002, Thrombosis research.

[12]  Thomas M. Smith,et al.  Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases. , 2002, Archives of biochemistry and biophysics.

[13]  R. Busto,et al.  Neuroprotective Effect of SolCD 39 , a Novel Platelet Aggregation Inhibitor , on Transient Middle Cerebral Artery Occlusion in Rats , 2003 .

[14]  R. Busto,et al.  Neuroprotective Effect of SolCD39, a Novel Platelet Aggregation Inhibitor, on Transient Middle Cerebral Artery Occlusion in Rats , 2003, Stroke.

[15]  Thomas M. Smith,et al.  Structure and Protein Design of a Human Platelet Function Inhibitor , 2004, Cell.

[16]  Michael V Sefton,et al.  Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. , 2004, Biomaterials.

[17]  M. J. Broekman,et al.  Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and Cardioprotection , 2005, Seminars in thrombosis and hemostasis.

[18]  M. J. Broekman,et al.  Effects of SolCD39, a Novel Inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model , 2005, Journal of Thrombosis and Thrombolysis.

[19]  B. Nilsson,et al.  Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. , 2006, Journal of biomedical materials research. Part A.

[20]  B. Nilsson,et al.  Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.

[21]  John D Lambris,et al.  Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated platelets , 2008, Journal of thrombosis and haemostasis : JTH.

[22]  R. Lai,et al.  Antihemostatic molecules from saliva of blood-feeding arthropods , 2008 .

[23]  Anna E. Engberg,et al.  Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. , 2009, Biomaterials.

[24]  Bo Nilsson,et al.  Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. , 2009, Biomaterials.

[25]  John D Lambris,et al.  Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? , 2010, Trends in immunology.